Schizophrenia Trial, Recruiting NCT05299749 Sponsor: Boston VA Research Institute, Inc. Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05299749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with schizophrenia or schizoaffective disorder based on standard medical guidelines (DSM-5)
  • You hear voices (auditory hallucinations) that have not gotten better with medication, as confirmed by your medical records and a structured interview

Who may not be able to join:

  • You have a neurological illness or condition affecting the brain or nervous system
  • You have had a serious head injury in the past
  • You have previously received electroconvulsive therapy (ECT), sometimes called "shock therapy"
  • You are currently dependent on alcohol or drugs
  • You have misused or abused alcohol or drugs at any point within the last five years
  • Your verbal IQ score is below 70, as measured by a standardised test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: margaret niznikiewicz, Boston VA Research Institute, Inc.

Phone: 6176534627

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston VA Research Institute, Inc.
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

percent change in the STG BOLD signal, post- relative to pre-NFB

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov